Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
Muhammad AliAngelos G RigopoulosMammad MammadovAbdelrahman TorkyAndrea AuerMarios MatiakisElena AbateConstantinos BakogiannisStergios TzikasBoris BigalkeDaniel SeddingMichel NoutsiasPublished in: BMC cardiovascular disorders (2020)
This systematic review on the LAmbre™ LAA-occluder including n = 403 NVAF patients demonstrates an excellent implantion success rate, promising follow-up clinical data, and favorable properties for also challenging LAA anatomies,. While its design seems to be helpful in preventing device embolization, pericardial tamponade may not be substantially reduced by the LAmbre™ as compared with other established LAAC devices. Further larger prospective multicenter registries and randomized trials are needed to scrutinize the value of the LAmbre™ compared with established LAAC devices.
Keyphrases
- left atrial appendage
- atrial fibrillation
- systematic review
- catheter ablation
- meta analyses
- oral anticoagulants
- left atrial
- end stage renal disease
- direct oral anticoagulants
- ejection fraction
- heart failure
- chronic kidney disease
- newly diagnosed
- percutaneous coronary intervention
- electronic health record
- clinical trial
- patient reported outcomes
- venous thromboembolism
- coronary artery disease
- acute coronary syndrome
- patient reported